Rock Springs Capital Management LP Pliant Therapeutics, Inc. Transaction History

Rock Springs Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$1.35 - $13.53 $250,020 - $2.51 Million	185,200 Added 45.75%	589,996 $796,000
Q4 2024 Feb 14, 2025	BUY	$10.55 - $15.7 $208,890 - $310,860	19,800 Added 5.14%	404,796 $5.33 Million
Q4 2023 Feb 14, 2024	SELL	$12.85 - $19.15 $1.36 Million - $2.03 Million	-106,225 Reduced 21.62%	384,996 $6.97 Million
Q1 2023 May 15, 2023	BUY	$18.73 - $36.26 $9.2 Million - $17.8 Million	491,221 New	491,221 $13.1 Million

108

58.2M

209K

102K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $84.2M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.